Investment Rating - The report maintains a "Buy" rating for both A-shares and H-shares of the company [1][7] Core Views - The company achieved an operating revenue of 239.24 billion RMB in the first half of 2025, a year-on-year increase of 2.1%, and a net profit attributable to shareholders of 40.93 billion RMB, up 6.9% year-on-year [4] - New business value (NBV) grew by 20.3% year-on-year to 28.55 billion RMB, indicating strong growth in new business segments [6] - The company is focusing on value creation and transformation, with a strategic emphasis on optimizing business structure and cost efficiency [7] Summary by Sections Financial Performance - The company reported a net profit of 40.93 billion RMB for H1 2025, with a return on equity of 7.8%, remaining stable year-on-year [4] - Total investment income increased by 4.2% to 127.51 billion RMB, contributing to the overall profit growth [4] Business Development - Premium income reached 525.09 billion RMB, a 7.3% increase year-on-year, driven by renewal business growth [5] - The new business value of 28.55 billion RMB reflects a significant improvement in margins and value rates [6] Investment Strategy - The total investment asset scale reached 7.1 trillion RMB, with stock assets increasing by 23.8% to 620.1 billion RMB, now accounting for 8.7% of total investments [6] - The company is actively exploring innovations in health and elderly care services, which are expected to enhance its core insurance business [7] Profit Forecast and Valuation - The report forecasts net profits of 104.3 billion RMB for 2025, with a projected PEV of 0.82 for A-shares and 0.44 for H-shares [8][7]